1. Do Patient-reported Outcome Measures Agree with Clinical and Photographic Assessments of Normal Tissue Effects after Breast Radiotherapy? The Experience of the Standardisation of Breast Radiotherapy (START) Trials in Early Breast Cancer. Issue 6 (June 2016) Authors: Haviland, J.S.; Hopwood, P.; Mills, J.; Sydenham, M.; Bliss, J.M.; Yarnold, J.R. Journal: Clinical oncology Issue: Volume 28:Issue 6(2016) Page Start: 345 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. OC-0101 First results of FAST-Forward phase 3 RCT nodal substudy: 3-year normal tissue effects. (May 2022) Authors: Wheatley, D.; Haviland, J.; Patel, J.; Sydenham, M.; Alhasso, A.; Chan, C.; Cleator, S.; Coles, C.; Donovan, E.; Kirby, A.; Kirwan, C.; Nabi, Z.; Sawyer, E.; Somaiah, N.; Syndikus, I.; Venables, K.; Yarnold, J.; Brunt, A.M.; Bliss, J. Journal: Radiotherapy and oncology Issue: Volume 170(2022)Supplement 1 Page Start: S75 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. OC-0265: Evaluating variability of contouring using ESTRO guidelines for elective breast cancer radiotherapy. (May 2017) Authors: Megias, D.; Sydenham, M.; Wheatley, D.; Maclennan, M.; Spezi, E.; Brunt, A.M. Journal: Radiotherapy and oncology Issue: Volume 123:(2017:May)Supplement 1 Page Start: S136 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. OC-0595: FAST-Forward phase 3 RCT of 1-week hypofractionated breast radiotherapy:3-year normal tissue effects. (April 2018) Authors: Brunt, A.M.; Haviland, J.; Sydenham, M.; Al-hasso, A.; Bloomfield, D.; Chan, C.; Churn, M.; Cleator, S.; Coles, C.; Emson, M.; Goodman, A.; Griffin, C.; Harnett, A.; Hopwood, P.; Kirby, A.; Kirwan, C.; Morris, C.; Sawyer, E.; Somaiah, N.; Syndikus, I. Journal: Radiotherapy and oncology Issue: Volume 127(2018)Supplement 1 Page Start: S311 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. PO-093: COSTAR trial results: 3-D Conformal Radiotherapy vs Cochlea-Sparing IMRT in parotid cancer patients. (March 2017) Authors: Nutting, C.; Morden, J.; Beasley, M.; Bhide, S.; Emson, M.; Evans, M.; Fresco, L.; Gujral, D.; Harrington, K.; Lemon, C.; Neupane, R.; Newbold, K.; Prestwich, R.; Robinson, M.; Sanghera, P.; Sivaramalingam, M.; Sydenham, M.; Wells, E.; Witts, S.; Hall, E. Journal: Radiotherapy and oncology Issue: Volume 122(2017)Supplement 1 Page Start: 44 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗